Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand S Rerks-Ngarm, P Pitisuttithum, S Nitayaphan, J Kaewkungwal, J Chiu, ... New England Journal of Medicine 361 (23), 2209-2220, 2009 | 3795 | 2009 |
Immune-correlates analysis of an HIV-1 vaccine efficacy trial BF Haynes, PB Gilbert, MJ McElrath, S Zolla-Pazner, GD Tomaras, ... New England Journal of Medicine 366 (14), 1275-1286, 2012 | 2144 | 2012 |
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ... Science 375 (6576), 43-50, 2022 | 1054 | 2022 |
Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys JB Whitney, AL Hill, S Sanisetty, P Penaloza-MacMaster, J Liu, M Shetty, ... Nature 512 (7512), 74-77, 2014 | 750 | 2014 |
Vaccine protection against Zika virus from Brazil RA Larocca, P Abbink, JPS Peron, PM de A. Zanotto, MJ Iampietro, ... Nature 536 (7617), 474-478, 2016 | 609 | 2016 |
The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression NL Michael, G Chang, LG Loum, JR Mascola, D Dondero, DL Birx, ... Nature medicine 3 (3), 338-340, 1997 | 609 | 1997 |
Central nervous system viral invasion and inflammation during acute HIV infection V Valcour, T Chalermchai, N Sailasuta, M Marovich, S Lerdlum, ... The Journal of infectious diseases 206 (2), 275-282, 2012 | 596 | 2012 |
Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys P Abbink, RA Larocca, RA De La Barrera, CA Bricault, ET Moseley, ... Science 353 (6304), 1129-1132, 2016 | 566 | 2016 |
Genetic acceleration of AIDS progression by a promoter variant of CCR5 MP Martin, M Dean, MW Smith, C Winkler, B Gerrard, NL Michael, B Lee, ... Science 282 (5395), 1907-1911, 1998 | 560 | 1998 |
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys DH Barouch, J Liu, H Li, LF Maxfield, P Abbink, DM Lynch, MJ Iampietro, ... Nature 482 (7383), 89-93, 2012 | 528 | 2012 |
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2 M Rolland, PT Edlefsen, BB Larsen, S Tovanabutra, E Sanders-Buell, ... Nature 490 (7420), 417-420, 2012 | 491 | 2012 |
Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination NL Yates, HX Liao, Y Fong, A DeCamp, NA Vandergrift, WT Williams, ... Science translational medicine 6 (228), 228ra39-228ra39, 2014 | 489 | 2014 |
A recombinant vesicular stomatitis virus Ebola vaccine JA Regules, JH Beigel, KM Paolino, J Voell, AR Castellano, Z Hu, ... New England Journal of Medicine 376 (4), 330-341, 2017 | 462 | 2017 |
SARS-CoV-2 variants in patients with immunosuppression L Corey, C Beyrer, MS Cohen, NL Michael, T Bedford, M Rolland New England Journal of Medicine 385 (6), 562-566, 2021 | 459 | 2021 |
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG GD Tomaras, G Ferrari, X Shen, SM Alam, HX Liao, J Pollara, ... Proceedings of the National Academy of Sciences 110 (22), 9019-9024, 2013 | 458 | 2013 |
Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family M Bonsignori, J Pollara, MA Moody, MD Alpert, X Chen, KK Hwang, ... Journal of virology 86 (21), 11521-11532, 2012 | 448 | 2012 |
Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2 HX Liao, M Bonsignori, SM Alam, JS McLellan, GD Tomaras, MA Moody, ... Immunity 38 (1), 176-186, 2013 | 447 | 2013 |
Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines AW Chung, M Ghebremichael, H Robinson, E Brown, I Choi, S Lane, ... Science translational medicine 6 (228), 228ra38-228ra38, 2014 | 446 | 2014 |
Influence of HLA-C expression level on HIV control R Apps, Y Qi, JM Carlson, H Chen, X Gao, R Thomas, Y Yuki, ... Science 340 (6128), 87-91, 2013 | 415 | 2013 |
Effects of CCR5-Δ 32, CCR2-64I, and SDF-1 3′A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data JPA Ioannidis, PS Rosenberg, JJ Goedert, LJ Ashton, TL Benfield, ... Annals of internal medicine 135 (9), 782-795, 2001 | 396 | 2001 |